Breaking News Instant updates and real-time market news.

ALGN

Align Technology

$381.50

9 (2.42%)

16:53
07/25/18
07/25
16:53
07/25/18
16:53

Align Technology sees FY18 revenue growth in 'low to mid 30's'

Based on the momentum in Align Technology's business to-date and its planned investments for the remainder of the year, the company now anticipate FY18 total revenue growth rate to be above its long-term model and in the low to mid 30's. Align expects Invisalign revenue and volume growth to be in low 30's. Notwithstanding continued investments in the company's strategic growth drivers, it expects operating margin for FY18 to be slightly up from a FY17 operating margin of 24%. These comments were taken from Align Technology's Q2 earnings conference call slide presentation.

  • 25

    Jul

  • 27

    Aug

ALGN Align Technology
$381.50

9 (2.42%)

06/26/18
NRCS
06/26/18
NO CHANGE
Target $430
NRCS
Buy
Align Technology price target raised to $430 from $355 at Northcoast
Northcoast analyst Ed Snyder reiterated a Buy rating and raised his price target on Align Technology to $430 from $355 after completing a monthly review of North American Invisalign doctors, which now exceeds 22,000 total doctors. Snyder tells investors in a research note that Align has seen a nearly 5% shift of doctors from its low-volume bronze tier to its much higher-volume Silver, Gold, Platinum, and Diamond tiers within the last 30 days, and that, as of April 2018, 43.7% of doctors are Bronze, 45.0% are Silver tier, 2.0% are Gold tier, 4.7% are Gold Plus tier, 2.4% are Platinum-tier, and 1.0% are Platinum Plus tier. Snyder raised his FY18 EPS forecast to $5.00 from $4.95 to $5.00 and his FY19 EPS forecast to $6.47 from $6.42 to better reflect improving utilization trends, and expects the company to generate "impressive" internal growth rates, driven by double-digit increases in doctor utilization rates.
07/02/18
SPHN
07/02/18
NO CHANGE
Target $265
SPHN
Equal Weight
Align Technology chancery court victory not a surprise, says Stephens
Stephens analyst Chris Cooley said he was not surprised that a chancery court of Tennessee ruled to deny SmileDirectClub's request for a temporary injunction to stop Align Technology from opening new Invisalign Stores. He continues to view Align as the undisputed industry leader regardless of SmileDirectClub's litigation, though Cooley keeps an Equal Weight rating on the shares, citing valuation. He has a $265 price target on Align Technology.
07/18/18
GSCO
07/18/18
NO CHANGE
Target $43
GSCO
Sell
Dentsply Sirona and Patterson Companies guidance at risk, says Goldman Sachs
Goldman Sachs analyst Robert Jones kept his Sell rating on Dentsply Sirona (XRAY) and Patterson Companies (PDCO) while lowering his price target on the former to $43 from $45 and keeping that of the latter at $21. Jones says his Q2 dental survey indicates a "modest softening in consumable purchases and a slightly greater slowdown in equipment spending" reported by U.S. dentists, which puts the guidance of those companies at risk. The survey also revealed that the outlook for dental specialties lik implants and ortho is still more robust, suggesting a mid-single-digit implant market growth rate. The analyst is also positive on Align Technology (ALGN), keeping its Buy rating and raising its price target to $440 from $344 amid the "strong worldwide growth in 'Invisalign' search data" and the continued rollout of iTero in China.
07/20/18
PIPR
07/20/18
NO CHANGE
Target $425
PIPR
Overweight
Align Technology price target raised to $425 from $325 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for Align Technology to $425 after refreshing his analysis on new competition. The analyst continues to believe that competition will not dampen Align's growth profile. He says competing products are not as comprehensive and carry less of a discount to Invisalign than he previously assumed. Further, O'Brien thinks the market opportunity for clear aligners can grow larger than many investors realize. The analyst is confident that Align can sustainably grow sales 20%-30% for multiple years. He encourages investors to build positions, "even at current levels," and reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

CHEOY

Cochlear

$0.00

(0.00%)

05:20
07/17/19
07/17
05:20
07/17/19
05:20
Downgrade
Cochlear rating change  »

Cochlear downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BURBY

Burberry

$0.00

(0.00%)

05:18
07/17/19
07/17
05:18
07/17/19
05:18
Downgrade
Burberry rating change  »

Burberry downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPI

SPI Energy

$2.26

0.03 (1.35%)

05:17
07/17/19
07/17
05:17
07/17/19
05:17
Hot Stocks
SPI Energy appoints Anthony Chan as CFO »

SPI Energy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEA

Lear

$129.75

-5.33 (-3.95%)

05:15
07/17/19
07/17
05:15
07/17/19
05:15
Downgrade
Lear rating change  »

Lear downgraded to Sector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

NUS

Nu Skin

$45.50

1.44 (3.27%)

05:14
07/17/19
07/17
05:14
07/17/19
05:14
Downgrade
Nu Skin rating change  »

Nu Skin downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

CHAC

Chardan Healthcare

$9.81

(0.00%)

05:13
07/17/19
07/17
05:13
07/17/19
05:13
Hot Stocks
Chardan Healthcare announces merger agreement with BiomX »

Chardan Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEVI

Levi Strauss

$19.81

-0.3 (-1.49%)

, RL

Ralph Lauren

$115.16

2.555 (2.27%)

05:11
07/17/19
07/17
05:11
07/17/19
05:11
Downgrade
Levi Strauss downgraded to Sell from Neutral at Goldman Sachs »

Goldman Sachs analyst…

LEVI

Levi Strauss

$19.81

-0.3 (-1.49%)

RL

Ralph Lauren

$115.16

2.555 (2.27%)

PVH

PVH Corp.

$92.50

2.08 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 01

    Aug

  • 19

    Sep

  • 19

    Sep

CRZO

Carrizo Oil & Gas

$11.21

0.5 (4.67%)

05:11
07/17/19
07/17
05:11
07/17/19
05:11
Downgrade
Carrizo Oil & Gas rating change  »

Carrizo Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$115.16

2.555 (2.27%)

05:08
07/17/19
07/17
05:08
07/17/19
05:08
Downgrade
Ralph Lauren rating change  »

Ralph Lauren downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 01

    Aug

  • 19

    Sep

PVH

PVH Corp.

$92.50

2.08 (2.30%)

05:06
07/17/19
07/17
05:06
07/17/19
05:06
Downgrade
PVH Corp. rating change  »

PVH Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

PVH

PVH Corp.

$92.50

2.08 (2.30%)

05:06
07/17/19
07/17
05:06
07/17/19
05:06
Downgrade
PVH Corp. rating change  »

PVH Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SHLX

Shell Midstream

$21.52

0.32 (1.51%)

05:02
07/17/19
07/17
05:02
07/17/19
05:02
Downgrade
Shell Midstream rating change  »

Shell Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$140.43

2.02 (1.46%)

05:00
07/17/19
07/17
05:00
07/17/19
05:00
Upgrade
Hershey rating change  »

Hershey upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SGEN

Seattle Genetics

$63.12

-0.87 (-1.36%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Upgrade
Seattle Genetics rating change  »

Seattle Genetics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Credit Suisse energy analysts to hold an analyst/industry conference call »

Analysts provide a 2Q…

KSHB

KushCo Holdings

$0.00

(0.00%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
KushCo Holdings management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

TELL

Tellurian

$7.68

-0.1 (-1.29%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Tellurian management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

DOVA

Dova Pharmaceuticals

$16.07

(0.00%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Dova Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

CRD.B

Crawford & Company

$9.34

-0.13 (-1.37%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Crawford & Company management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

04:55
07/17/19
07/17
04:55
07/17/19
04:55
General news
Breaking General news story  »

Week of 7/12 MBA Mortgage…

PANW

Palo Alto Networks

$219.83

0.41 (0.19%)

, FTNT

Fortinet

$84.79

-0.19 (-0.22%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
FBN Securities Tech/Internet analyst to hold a group luncheon »

Analyst Seyrafi holds a…

PANW

Palo Alto Networks

$219.83

0.41 (0.19%)

FTNT

Fortinet

$84.79

-0.19 (-0.22%)

PFPT

Proofpoint

$126.33

0.61 (0.49%)

CHKP

Check Point

$116.24

-1.37 (-1.16%)

SAIL

SailPoint

$20.12

-0.27 (-1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 24

    Jul

  • 25

    Jul

  • 01

    Aug

  • 06

    Aug

  • 21

    Aug

  • 21

    Aug

  • 13

    Nov

OVID

Ovid Therapeutics

$2.39

-0.19 (-7.36%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Ovid Therapeutics management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

CLNE

Clean Energy

$2.75

-0.01 (-0.36%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Clean Energy management to meet with Craig-Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

  • 24

    Jul

  • 08

    Aug

VFF

Village Farms

$9.29

-0.125 (-1.33%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Village Farms management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

CASY

Casey's General Stores

$160.35

0.98 (0.61%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Casey's General Stores management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.